Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of June 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide comprehensive financial statements such as revenue, profit, cash flow, margins, or debt levels. The only financial data disclosed relates to the specific share repurchase transaction:
- Shares Purchased: 991,883 ordinary shares
- Purchase Date: June 17, 2025
- Highest Price Paid: 388.90 pence per share
- Lowest Price Paid: 384.70 pence per share
- Volume Weighted Average Price: 386.66 pence per share
Material Changes
Following the settlement of the buyback transaction, the company's registered share capital stands at 8,994,593,910 ordinary shares of £0.01 each. Of these, 4,080,205 are held as treasury shares. Consequently, the number of ordinary shares with voting rights is 8,990,513,705.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. It is a routine disclosure of a share repurchase activity in compliance with the Market Abuse Regulation.
Investor Verification Checklist
- Verify the total number of shares purchased (991,883) and the average price paid (386.66 pence) against the company's broader buyback programme limits.
- Confirm the updated count of voting shares (8,990,513,705) for disclosure threshold calculations under FCA rules.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link for granular execution details.